FDA front-of-package labeling: what's actually true right now
The FDA front of package labeling rule is not final. It is a proposed rule. There is no compliance date, and you have no deadline to meet today.
on this page +−
If you landed here because a blog post or a LinkedIn thread told you there's a 2026 front-of-pack deadline coming for your hot sauce or your granola, that post is wrong. We'll show you the docket.
Status box
| Rule name | Food Labeling: Front-of-Package Nutrition Information |
| Docket | FDA-2024-N-2910 |
| RIN | 0910-AI80 |
| Proposed rule published | January 16, 2025 |
| Comment period closed | July 15, 2025 (extended from May 16, 2025) |
| Current status | PROPOSED — NOT FINAL |
| Compliance date in effect | None. There is no compliance date. |
| Would create | A new section, 21 CFR 101.6 |
Last reviewed: August 2, 2026.
Source: FDA proposed rule, Federal Register, January 16, 2025 and the comment period extension published May 9, 2025. As of this review date, those two documents are the only rulemaking documents in docket FDA-2024-N-2910. No final rule has been published.
Where the "2026 deadline" story comes from
Two things got mashed together.
The first is Canada. The Canadian Food Inspection Agency set a front-of-package nutrition symbol deadline of January 1, 2026, and stated there would be no enforcement discretion after that date. That is a real deadline. It is a real deadline in Canada, for products sold in Canada, under Canadian Food and Drug Regulations. It has nothing to do with the FDA. You can read it on inspection.canada.ca.
The second is that FDA's own regulatory agenda has, at various points, projected a final rule sometime in 2026. A projection on an agenda is not a rule. It is a plan, and plans slip constantly. Even if FDA published a final rule tomorrow, the earliest compliance date under the proposal as written would be three years after that rule took effect.
Content farms scraped both, dropped the country and the conditional, and produced a deadline that does not exist.
What the rule would require if it is finalized
The proposal would add a standardized box to the front of most packaged foods. FDA's own term for it is the "Nutrition Info box." It is not a warning label, and calling it one misrepresents both the design and the intent. It does not say "high in sugar, do not eat." It reports numbers you already have.
The three nutrients. Saturated fat, sodium, and added sugars. Each one gets its percent Daily Value plus an interpretive word: Low, Med, or High. Calories may be shown voluntarily but are not required in the proposed format.
The thresholds. These follow FDA's longstanding 5/20 convention for reading a percent Daily Value:
| Rating | Percent Daily Value |
|---|---|
| Low | 5% DV or less |
| Med | More than 5% and less than 20% DV |
| High | 20% DV or more |
Placement. The box would go on the principal display panel, the front of the package, positioned so it is visible while a shopper is deciding whether to buy the product.
Package size carve-outs. Two matter for small operators:
- Packages with less than 12 square inches of available labeling surface would be exempt entirely.
- Packages with 40 square inches or fewer could use a modified, condensed version of the box.
That second one covers a lot of spice tins, single-serve sachets, and small jars. A meaningful share of cottage-scale products would land in one of these two buckets.
The proposed compliance timeline, and why every word of it is conditional
If the rule is finalized as proposed, the clock would run from the final rule's effective date, not from publication and not from today:
| Business size | Time to comply after the effective date |
|---|---|
| $10 million or more in annual food sales | 3 years |
| Under $10 million in annual food sales | 4 years |
Read that carefully. Every one of those years is downstream of a final rule that does not exist. There is no rule, so there is no effective date, so there is no clock. If FDA finalized the rule in mid-2027, a business under $10 million in food sales would be looking at roughly 2031. If FDA withdraws the proposal, the answer is never.
The political situation, stated plainly
This is where honest coverage matters, because the rule's future is genuinely unsettled and nobody can tell you how it ends.
FDA leadership changed twice in the period since the proposal. Commissioner Marty Makary departed the agency in May 2026. Kyle Diamantas, previously Acting Deputy Commissioner for Human Foods, was elevated to Acting Commissioner (Axios, May 13, 2026).
Both men had gone on record with reservations. Makary, speaking on a panel at the National Food Policy Conference in March 2026, said leadership "did not like the front-of-package plan that we inherited." Diamantas, in remarks reported by trade press, indicated that everything is on the table for the proposal, including revising it or rescinding it outright, and noted that changing the substance or design of the labeling framework could itself trigger fresh procedural requirements under the Administrative Procedure Act. That last point matters: a significantly redesigned box would likely require FDA to go back out for comment, adding a year or more.
A note on sourcing. We could not locate a primary FDA transcript or press release carrying either statement. Both come to us through legal and regulatory trade press reporting, principally this analysis from Keller and Heckman, which attributes the Diamantas remarks to a Bloomberg Law interview. We are reporting them as reported, not as verified agency positions.
Pulling against that: the rule was still carried on FDA's 2026 Unified Regulatory Agenda as a pending final rule as of mid-2026, and it has appeared among the Human Foods Program's priority deliverables. Career staff have been working through the comment file. The agenda listing and the leadership skepticism are both real, and they point in different directions.
Three outcomes are all live: FDA finalizes something close to the proposal, FDA finalizes something materially different (which may restart the comment process), or FDA withdraws it. We don't know. Anyone telling you they do is selling something.
What you should actually do right now
The honest answer is nothing urgent. There is no action item. There is no filing. There is no design change you need to commission.
That said, here's what a sensible operator does, and none of it is wasted effort even if the rule dies:
1. Know your saturated fat, sodium, and added sugars numbers. This is the whole thing. You already need all three for your Nutrition Facts panel under 21 CFR 101.9. If you have a compliant panel, you already have every number the Nutrition Info box would display. There is no new testing, no new analysis, no new cost. The proposed rule adds a rendering step, not a data step.
2. Glance at your percent DVs. If saturated fat, sodium, or added sugars are sitting at 20% DV or higher per serving, that's what would print as "High." Worth knowing now, quietly, so it's not a surprise in three years. It is not a reason to reformulate today.
3. Measure your label panel. If your principal display panel is under 12 square inches, the proposal as written exempts you outright. Under 40 square inches, you'd get the condensed version. Small-format sellers may find this rule barely touches them.
4. Don't buy anything sold on this deadline. If a vendor, consultant, or agency pitches you front-of-pack compliance services with a 2026 or 2027 urgency hook, they are either misinformed or counting on you being misinformed. There is nothing to comply with.
5. Check back, don't subscribe to panic. This page is dated and we revise it. If the rule moves, the status box at the top changes.
If you don't have your saturated fat, sodium, and added sugars numbers yet, that's the actual gap, and it's a Nutrition Facts panel problem, not a front-of-pack problem. Nutrillius builds an FDA-compliant panel from your recipe in about a minute. $39 one time, no subscription.
Changelog
We review this page quarterly and after any movement in docket FDA-2024-N-2910.
| Date reviewed | What changed |
|---|---|
| August 2, 2026 | Confirmed no final rule published; docket still contains only the January 16, 2025 proposal and the May 9, 2025 comment extension. Added FDA leadership change: Makary departed May 2026, Diamantas named Acting Commissioner. Added the Canada January 1, 2026 deadline as the likely origin of the "2026 deadline" misinformation. |
| Next scheduled review | November 2026 |
Frequently asked questions
Is the FDA front of package rule final?
When do I have to comply with the FDA front of package labeling rule?
Is the FDA front of package label a warning label?
Does the front of package rule apply to small packages?
Could the FDA front of package rule be withdrawn?
Keep reading
The FDA small business labeling exemption, and whether you qualify
Read →Nutrient content claims that void your labeling exemption
Read →Can you say "healthy" on your food label? The new FDA rule
Read →Added sugars: how to calculate the number for your panel
Read →Serving size and the RACC table, explained
Read →